Ålesund
Ålesund
Ålesund, Møre og Romsdal, Norway7 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease | Crohn disease, Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder | Recruiting | Phase 2 | 2026-09-25 | NCT06548542 | |
| Reestablishing Normal Gut-brain Interaction in Anorexia Nervose With Normal Gut Microbiota | Feeding and Eating Disorders, anorexia nervosa, psychiatric disorder | Not yet recruiting | Phase 1 | 2026-09-24 | NCT07574892 | |
| Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 3 | 2026-09-10 | NCT05448547 | |
| A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease | Crohn disease, Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder | Active, not recruiting | Phase 3 | 2026-08-14 | NCT03105102 | |
| ATTR Cardiac Amyloidosis in a Selected Population | Amyloid Neuropathies, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cumulative Trauma Disorders, Nutritional and Metabolic Diseases, Sprains and Strains, amyloidosis, carpal tunnel syndrome, familial amyloid neuropathy, hereditary amyloidosis, hereditary disease, inborn errors of metabolism, inherited neurodegenerative disorder, injury, median nerve neuropathy, metabolic disease, mononeuropathy, nerve compression syndrome, nervous system disorder, neurodegenerative disease, neuromuscular disease, peripheral nervous system disorder, proteostasis deficiencies | Recruiting | Not stated | 2026-08-12 | NCT06458374 | |
| Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes | Arterial Occlusive Diseases, Dyslipidemias, Hypercholesterolemia, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, arteriosclerosis disorder, cardiovascular disorder, hyperlipidemia, metabolic disease, vascular disorder | Active, not recruiting | Phase 3 | 2026-04-23 | NCT06008756 | |
| Modern Technologies in Lower Respiratory Tract Infections in Children | childhood onset asthma | Recruiting | Not stated | 2026-02-02 | NCT07381790 |